Emil List Larsen, Henning Nilius, Jan-Dirk Studt, Dimitrios A Tsakiris, Andreas Greinacher, Adriana Mendez, Adrian Schmidt, Walter A Wuillemin, Bernhard Gerber, Prakash Vishnu, Lukas Graf, Johanna A Kremer Hovinga, Jens P Goetze, Tamam Bakchoul, Michael Nagler
IMPORTANCE: Heparin-induced thrombocytopenia (HIT) is a life-threatening condition that requires urgent diagnostic clarification. However, knowledge of the diagnostic utility of the recommended diagnostic tests is limited in clinical practice. OBJECTIVE: To evaluate the current diagnostic practice for managing the suspicion of HIT. DESIGN, SETTING, AND PARTICIPANTS: This prospective diagnostic study was conducted from January 2018 to May 2021 among consecutive patients with suspected HIT from 11 study centers in Switzerland, Germany, and the United States...
March 4, 2024: JAMA Network Open